Oncology PracticeFirst reported case of tumor hypoglycemia from recurrent renal cell carcinomaApril 17, 2014Genitourinary Cancer
Oncology PracticeProphylactic tadalafil ineffective after prostate cancer radiotherapyApril 1, 2014Genitourinary Cancer
Oncology PracticeBiomarkers in urine outperformed cytology and cytoscopyApril 1, 2014Genitourinary Cancer
Oncology PracticeLow UTI rates after foregoing prophylactic antibiotics for cystoscopyMarch 27, 2014Genitourinary Cancer
Oncology PracticeProstate cancer screening fell in wake of trial results, task force recommendationsMarch 27, 2014Genitourinary Cancer
Oncology PracticeI-125 brachytherapy for prostate cancer linked to small increase in bladder cancer riskMarch 25, 2014Genitourinary Cancer
Oncology PracticeNo benefit from androgen deprivation therapy in localized prostate cancerMarch 25, 2014Genitourinary Cancer
Oncology PracticeThe push for smaller, smarter cancer trialsMarch 17, 2014Breast CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
Oncology PracticePositive surgical margins do not independently predict prostate cancer mortalityMarch 17, 2014Genitourinary Cancer
Oncology PracticeProstatectomy found superior to watchful waiting over long term March 5, 2014Genitourinary Cancer
Oncology PracticeProstate cancer death rate highest in MontanaFebruary 13, 2014Genitourinary CancerBusiness of MedicinePractice Management
Oncology PracticeBeta-blockers linked to lower mortality in high-risk prostate cancer February 10, 2014Genitourinary Cancer
Oncology PracticeIMDC model is validated in setting of second-line targeted therapyFebruary 7, 2014Genitourinary Cancer
Oncology PracticeAt least a third of low-risk cancers get upgraded at prostatectomyFebruary 6, 2014Genitourinary Cancer
